The Longevity Buffet — Issue 02
Hackathon announcement and more!
Welcome to the Longevity Buffet Newsletter 🗞️
First things first, WE JUST ANNOUNCED LONDON’S FIRST AI FOR LONGEVITY HACKATHON, HAPPENING 30 May to 1 June 🥳🤖🧬⌛
The 3 days will be packed with exciting things -
🧠 Talks & workshops on AI, biotech, and the science of ageing
🛠 Credits, mentorship & support to take your idea to MVP fast
🏆 Cash prizes, lab space, mentorship and credits for winning teams
Come join us if you are an AI/software engineer, researcher, scientist, or founder who wants to build tools and projects that push the boundaries of longevity science. You don’t need a team or an idea, just curiosity and a desire to build the future of health.
Opening Day is for anyone interested in the longevity space, not just hackers.
SIGN UP and SHARE WITH FRIENDS!
Read more at hackathon.londonlongevity.net
-
In case you missed Issue 01 of the Longevity Buffet, this is a new curated newsletter from us to you, which we started off short and sweet, with assorted links on the latest in longevity science and business. Feedback always welcome to evolve the format.
Here goes Issue 02!
RESEARCH/READING SPOTLIGHT 🧬
Anti-aging protein α-Klotho is potential for reducing comorbidity risk of cardiometabolic diseases in vulnerable populations and enhancing long-term prognosis - Read More
A window into the future of personalised medicine - The inside story of the six-month sprint to create the first custom CRISPR therapy for one infant’s rare disease - Read More
MARKET MOMENTUM 💸
“We can now program life itself with the ever cheaper tools of synthetic biology. We believe this era of programmable biology will spark a new wave of entrepreneurs who push the limits of what biology can do.” - said by Union Square Ventures, a top-tier VC fund. USV, with its history of software investments, just announced their first ever bio investment and that they’re now actively investing in the space
XPRIZE Healthspan names top 100 teams advancing healthy aging, which includes 3 teams from London and Cambridge🥳
Some good news via a talk by Karl Pfleger at Vitalist Bay (I was there! ;)) - FDA approvals of ageing therapies have started - Watch Here
Therini Bio lands $39m to launch Alzheimer’s and DME trials
Older news, but ICYMI, NewLimit raised a $130M Series B round to reverse ageing
COOL NEW TOOL 🔨
If you’re an undergrad or know one, the f(Lux) Fellowship program by Lux Capital for undergrads is a cool opportunity, offering $15,000 non-dilutive grants, deep mentorship, and a world-class network for those working in:
🧬 Inner space (biology + healthcare)
🚀 Outer space (defense + aerospace + manufacturing)
🤖 Latent space (AI + computational infrastructure + open-source + crypto)
ALPHA (the edge of having unique insights *earlier* than others/the market to drive asymmetric returns) 👀
One Word - Biomanufacturing
That's a wrap for Issue 02!
See you again in a couple weeks,
Prasasya from London Longevity
Share your thoughts by replying to this email or joining our community on WhatsApp and LinkedIn.
Visit londonlongevity.net for upcoming announcements.